P

Praxis Precision Medicines

Clinical-stage biopharma developing CNS therapies

Clinical Development Leader - Lifecycle Management

Biology & BiotechConfirmed live in the last 24 hours
Full-timeRemote in USA$280k - $350k /yr

About the Job

Requirements

  • An advanced scientific degree (MD, PharmD, PhD, or equivalent) is required.
  • A track record of personally leading clinical trials, programs, submissions, or major development decisions.
  • Experience owning regulatory submissions, including carrying the clinical content of IND, CTA, NDA, or MAA filings, briefing books, and health authority interactions.
  • Strong judgment and the ability to make timely decisions on emerging data with incomplete information, including knowing what to escalate and when.
  • Comfort operating in a dynamic environment where priorities shift, scope evolves, and ownership matters more than rigid role boundaries.

Responsibilities

  • Identify and drive opportunities to expand the impact of late-stage and marketed assets, including new indications, label expansion, and formulation opportunities.
  • Lead first-in-human and dose-escalation studies, applying pharmacokinetic/pharmacodynamic (PK/PD) and emerging clinical data to dose selection, decision rules, and next-stage development.
  • Drive the clinical strategy and content for IND-enabling submissions and decisions required to move programs into human studies.
  • Work across mechanisms, indications, and phases, quickly developing the context needed to make sound clinical development decisions.
  • Interpret emerging clinical and scientific data, identify what matters, and make timely decisions when information is incomplete.
  • Drive cross-functional teams across clinical operations, biostatistics, regulatory, safety, translational sciences, and other disciplines, and represent Praxis with investigators, key opinion leaders, health authorities, and partners.

About the Company

Praxis Precision Medicines

Clinical-stage biopharma developing CNS therapies

Praxis Precision Medicines develops therapies for central nervous system disorders driven by neuronal imbalance, with a focus on genetic epilepsies. Its treatments target restoring balance in CNS networks and are advanced in clinical development to address unmet medical needs. The company differentiates itself by using patient-guided development and forming partnerships to align with real patient needs. Its goal is to bring effective CNS therapies to patients and caregivers by advancing through clinical development toward potential commercialization and collaborations.

Company size
201-500
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2015

Recently Posted Jobs

Explore more opportunities at Praxis Precision Medicines

See more jobs